Outsourced Clinical Trial and Formulation Market
Outsourced Clinical Trial and Formulation Market Study by Oral and Injectable Dosage Forms for API Manufacturing, Drug Product Development, and Packaging/Labeling from 2024 to 2034
Analysis of Outsourced Clinical Trial and Formulation Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Outsourced Clinical Trial and Formulation Market Outlook (2024 to 2034)
The global outsourced clinical trial and formulation market size is estimated at US$ 16.07 billion and is projected to expand at a CAGR of 6.6% to reach US$ 30.42 billion by 2034-end.
Businesses in the biotechnology and pharmaceutical sectors outsource clinical trials due to time constraints, cost considerations, and resources. Suppliers and contract research organizations (CROs) predominantly manage clinical studies. Advancements in technology, such as the adoption of AI and data analytics, are necessitating partnerships between CROs and technology companies.
Stringent regulatory requirements are necessitating expertise in compliance, which is driving companies to outsource clinical trials to ensure adherence to regulations. Dosage forms, such as tablets, suspensions, and liquids, incorporate active medicinal components. Consequently, an increasing number of companies are subcontracting API production to nations with cost-effective labor, driving the global demand for clinical trial outsourcing.
Key Drivers for Market Growth
- Operations in the pharmaceutical sector are intricate due to advancements in therapies, personalized drug approaches, and biologics.
- Industry players seek outsourcing partners with specialized knowledge and skills to navigate the complexities of clinical trial design, execution, and formulation.
- Outsourcing facilitates the development of new drugs and increases the likelihood of successful clinical trials supported by highly skilled scientists and advanced technology.
- Rising cost constraints and decreasing new drug development prompts pharmaceutical firms to optimize resource allocation and streamline operations.
- Contracting clinical trials and formulation processes enables drug sponsors to achieve cost reduction by leveraging the infrastructure and capabilities of CROs and contract development and manufacturing organizations (CDMOs).
- By outsourcing non-core activities, companies employ their internal resources for core competencies like drug discovery and commercialization, thus driving competitiveness in the global market.
- Clinical management systems play a pivotal role in both management and industry expansion.
| Report Attributes | Details |
|---|---|
| Outsourced Clinical Trial and Formulation Market Size (2024E) | US$ 16.07 Billion |
| Forecasted Market Value (2034F) | US$ 30.42 Billion |
| Global Market Growth Rate (2024 to 2034) | 6.6% CAGR |
| North America Market Share (2024E) | 44.2% |
| East Asia Market Value (2034F) | US$ 4.58 Billion |
| Sales of Oral Dosage Forms (2034F) | US$ 17.6 Billion |
| Small- and Medium-Size Pharma/Biotech Company Segment Value (2034F) | US$ 15.66 Billion |
| Key Companies Profiled | Piramal Pharma Solutions; Catalent, Inc.; SGS S.A.; Lonza Group; Siegfried Holding AG; Ascendia Pharmaceuticals; Charles River Laboratories International, Inc.; Quotient Sciences; Velesco Pharmaceutical Services, Inc.; Hermes Pharma GmbH; Eurofins Scientific SE; Elements Group (Avomeen); Evotec A.G.; VxP Pharma; Eurofins Scientific SE; Hovione; Enteris Biopharma, Inc.; Aenova Holding GmbH; KP Pharmaceutical Technology Inc.; NextPharma Technologies; Ardena Holding NV; Alcami Corporation, Inc.; Thermo Fisher Scientific Inc. (Patheon); Glatt GmbH; Pharmaceutics International, Inc.; Recipharm AB; Pace Analytical Services, LLC; Almac Group, Inc.; Corerx, Inc.; Cambrex Corporation; Aphena Pharma Solutions; Rottendorf Pharma GmbH |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What’s Behind Steady Outsourced Clinical Trial and Formulation Market Growth?
“Growing Investments in Research for Development of New Drugs”
The increasing demand for formulation development in the healthcare sector is resulting in heavy investments in research and development by companies. Due to the lack of capacity for formation development, some small- and medium-sized companies often use formulation development services. To remain competitive, companies are increasingly focusing on research and development, thereby fueling the expansion of the market.
“Collaborations Between Industry Players to Introduce Effective Medications and Gene Therapies”
Pharmaceutical firms play a pivotal role in driving the expansion of the outsourced clinical trial and formulation market size through their focus on cancer formulation development and other medication advancements. These industry leaders are collaborating to pioneer effective medications and gene therapies, leading to the growth of the biotech sector. Over the forecast period, market expansion is projected to be driven by the adoption of new methodologies, enhanced availability, and expanded pharmaceutical services by major players.
Delivering clinical and pharmacological substance development, as well as medicinal products, to patients stands as a primary objective. Market competitors are engaged in fierce competition to expand their businesses by innovating and introducing unique products that stimulate customer demand.
What are the Factors Affecting Market Growth to Some Extent?
“Insufficient Funding to Complete Formulation Development Phase”
The process of developing new drugs is highly time-consuming, costly, and challenging, with no guarantee of success. Each phase of the drug development process requires significant capital investment. These time-consuming procedures and low success rates drive up high research and development costs. Factors restricting the expansion of the market include shifts in the organizational structure of the pharmaceutical sector and insufficient funding to complete the formulation development phase of drug development.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
The North American region is a leading player in the outsourced clinical trial and formulation market and is estimated to hold 44.2% revenue share in 2024. Demand for outsourced clinical trials and formulation solutions is predicted to rise at 6.7% CAGR from 2024 to 2034.
What Makes the United States a Key Market in This Space?
“High Manufacturing Rate and Strong Clinical Infrastructure”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 5.98 Billion |
| Growth Rate (2024 to 2034) | 6.2% CAGR |
| Projected Value (2034F) | US$ 10.96 Billion |
The United States is generating a significant portion of revenue in North America because of high API manufacturing rates, excellent healthcare accessibility, and solid clinical research infrastructure. Further, government initiatives and incentive programs are also contributing to revenue growth players in the outsourced clinical trial and formulation business. The presence of key market players in the country is also supporting market growth.
Which Outsourced Clinical Trial and Formulation Market Trends are Significant in China?
“Growing Healthcare Sector and Government Initiatives Supporting Drug Development”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 1.43 Billion |
| Growth Rate (2024 to 2034) | 7% CAGR |
| Projected Value (2034F) | US$ 2.8 Billion |
In the East Asia region, China is projected to account for 59.3% of the outsourced clinical trial and formulation market share in 2024. The increasing demand for outsourced clinical trials and formulation solutions is the result of the growing healthcare sector in the country. Due to the strong manufacturing base, funding by companies and the government for the production of new drugs is creating new opportunities for players in the market.
- In January 2023, WuXi STA, an affiliate of WuXi AppTec, officially inaugurated its continuous production line. Located in Wuxi City, the line is integrated into the company's formulation development and production facility.
Category-wise Insights
By product type, the market is segmented into oral dosage forms and injectable dosage forms. Even though the oral dosage form accounts for a significant market share, the injectable dosage form segment is projected to expand at 7.5% CAGR from 2024 to 2034.
Why are Oral Dosage Forms Highly Sought After for Outsourced Formulation Development?
“Self-administrable Nature and Flexible Design of Oral Dosage Forms”
| Attribute | Oral Dosage Forms |
|---|---|
| Segment Value (2024E) | US$ 9.72 Billion |
| Growth Rate (2024 to 2034) | 6.1% CAGR |
| Projected Value (2034F) | US$ 17.6 Billion |
In 2024, oral dosage formulations are estimated to occupy 60.5% revenue share. Oral dosage formulations include tablets, syrups, capsules, powders, and many other products that are generally used for common diseases such as infections, fever, migraines, and diabetes. The fact that oral formulations are self-administrable and do not require a trained physician to administer the drug is one of the primary factors influencing their high popularity. These formulations also have more flexible designs than others, which makes them highly sought after for outsourced formulation development.
Why Do Most Pharmaceutical Companies Outsource API Manufacturing?
“Focus on Leveraging Expertise of CDMO and Reducing Costs”
| Attribute | API Manufacturing |
|---|---|
| Segment Value (2024E) | US$ 7.45 Billion |
| Growth Rate (2024 to 2034) | 6.3% CAGR |
| Projected Value (2034F) | US$ 13.79 Billion |
Dosage forms are typically produced separately from tablets, suspensions, and liquids, and therefore, an increasing number of companies are opting to outsource their API manufacturing to regions with lower labor costs. By doing so, emerging and virtual pharmaceutical firms are capitalizing on the operational expertise of contract development and manufacturing organizations (CDMOs).
These partnerships provide access to GMP facilities, quality assurance, safety measures, environmental management systems, standardized operating procedures, and advanced Chemistry, Manufacturing, and Control (CMC) technologies. This offers streamlined production processes and enhances overall efficiency.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the outsourced clinical trial and formulation market include Piramal Pharma Solutions, Catalent, Inc., SGS S.A., Lonza Group, Siegfried Holding AG, Ascendia Pharmaceuticals, Charles River Laboratories International, Inc., Quotient Sciences, Velesco Pharmaceutical Services, Inc., Hermes Pharma GmbH, Eurofins Scientific SE, Glatt GmbH, Pharmaceutics International, Inc., and Rottendorf Pharma GmbH.
- In November 2019, it was reported that Dr Reddy's Laboratories, which is placing a large bet on the Chinese market and intends to introduce over 70 items there, had begun contracting with local partners to manufacture a portion of its medication line.
Segmentation of Outsourced Clinical Trial and Formulation Market Research
-
By Product Type :
- Oral Dosage
- Solid Dosage
- Liquid Dosage
- Semi-solid Dosage
- Injectable Dosage
- Oral Dosage
-
By Application :
- API Manufacturing
- Fill-Finish Product Manufacturing
- Drug Product Development
- Packaging/Labeling
-
By End User :
- Big Pharmaceutical/Biotech Companies
- Small- & Medium-Size Pharma/Biotech Companies
- Emerging/Virtual Pharma Companies
- Nutraceutical Companies
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Background and Foundation Data Points
- 4. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
- 5.1. API Manufacturing
- 5.2. Fill-Finish Product Manufacturing
- 5.3. Drug Product Development
- 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product Type
- 6.1. Oral Dosage
- 6.2. Injectable Dosage
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
- 7.1. Big Pharmaceutical/Biotech Companies
- 7.2. Small- & Medium-Size Pharma/Biotech Companies
- 7.3. Emerging/Virtual Pharma Companies
- 7.4. Nutraceutical Companies
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. East Asia
- 8.5. South Asia & Oceania
- 8.6. Middle East and Africa (MEA)
- 9. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 10. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 11. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Market Structure Analysis
- 16. Competition Analysis
- 16.1. Piramal Pharma Solutions
- 16.2. Catalent, Inc.
- 16.3. SGS S.A.
- 16.4. Lonza Group
- 16.5. Siegfried Holding AG
- 16.6. Ascendia Pharmaceuticals
- 16.7. Charles River Laboratories International, Inc.
- 16.8. Quotient Sciences
- 16.9. Velesco Pharmaceutical Services, Inc.
- 16.10. Hermes Pharma GmbH
- 16.11. Eurofins Scientific SE
- 16.12. Elements Group (Avomeen)
- 16.13. Evotec A.G.
- 16.14. VxP Pharma
- 16.15. Hovione
- 16.16. Enteris Biopharma, Inc.
- 16.17. Aenova Holding GmbH
- 16.18. KP Pharmaceutical Technology Inc.
- 16.19. NextPharma Technologies
- 16.20. Ardena Holding NV
- 16.21. Alcami Corporation, Inc.
- 16.22. Thermo Fisher Scientific Inc. (Patheon)
- 16.23. Glatt GmbH
- 16.24. Pharmaceutics International, Inc.
- 16.25. Recipharm AB
- 16.26. Pace Analytical Services, LLC
- 16.27. Almac Group, Inc.
- 16.28. Corerx, Inc.
- 16.29. Cambrex Corporation
- 16.30. Aphena Pharma Solutions
- 16.31. Rottendorf Pharma GmbH
- 17. Assumptions and Acronyms Used
- 18. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Application, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Application, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Application, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Application, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Application, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Application, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the outsourced clinical trial and formulation market?
The global market for outsourced clinical trials and formulations is estimated at US$ 16.07 billion in 2024.
What are the projections for the global market by 2034?
Worldwide revenue from outsourced clinical trials and formulations is projected to reach US$ 30.42 billion by 2034-end.
How fast is market forecasted to expand?
The global outsourced clinical trial and formulation market is projected to advance at a CAGR of 6.6%.
What are the projections for the market in Mexico?
The Mexico market is estimated to reach US$ 601 million in 2024 and thereafter increase at 6% CAGR.
Who are the leading players in the outsourced clinical trial and formulation industry?
Piramal Pharma Solutions, Catalent, Inc., and SGS S.A. are some of the leading companies in the industry.
At what pace is the market projected to grow in Japan?
The market in Japan is projected to expand at a CAGR of 6.6% through 2034.
Outsourced Clinical Trial and Formulation Market